Position in EOLS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$140,923
+$42,263 QoQ
Shares Held
34,288
+179.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $402,454,379 across 27 Drug Manufacturers - Specialty & Generic names. EOLS ranks #22 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,063,170 | $243,887,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
119,235 | $70,703,969 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
961,140 | $28,949,535 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
184,222 | $24,269,403 | |
| 5 | VTRS |
Viatris Inc
|
1,715,900 | $23,181,805 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
84,159 | $1,747,140 | |
| 7 | ALKS |
Alkermes plc.
|
48,337 | $1,709,196 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
78,293 | $1,084,357 |
All Filings in EOLS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $140,923 | 34,288 | Shares | Defined | 2026-04-30 | |
| 2022-09-30 | $98,660 | 12,256 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,214,612 | 104,708 | Shares | Defined | 2022-08-11 | |
| 2021-12-31 | $68,752 | 10,561 | Shares | Defined | 2022-02-11 | |
| 2020-12-31 | $62,183 | 18,507 | Shares | Defined | 2021-02-25 | |
| No filing history on record for this holder in this stock. | ||||||